Showing results (81-90 of 131) with videos related to
Sort By:
Pageof 14
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.JAMA|July 20, 2014
Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfectionMark S Sulkowski, Susanna Naggie, Jacob Lalezari, et al.Hepatology (Baltimore, Md.)|February 7, 2014
All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infectionDavid L Wyles, Maribel Rodriguez-Torres, Eric Lawitz, et al.Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water LabelingRohit Loomba, Martin Decaris, Kelvin W Li, et al.Journal of Hepatology|November 7, 2017
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis BHarry L A Janssen, Maurizia R Brunetto, Yoon Jun Kim, et al.Gastroenterology|July 31, 2018
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver DiseaseRohit Loomba, Zeid Kayali, Mazen Noureddin, et al.Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.Hepatology (Baltimore, Md.)|January 21, 2019
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing CholangitisMichael Trauner, Aliya Gulamhusein, Bilal Hameed, et al.Journal of Hepatology|March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infectionEdward J Gane, Young-Suk Lim, Stuart C Gordon, et al.Pageof 14